{"entity":"merck","id":"ent_merck","name":"Merck & Co.","wikidata":"Q247489","page":"https://asof.is/record/merck","summary":"Merck & Co. is an American multinational pharmaceutical company, headquartered in Rahway. Its CEO is Rob Davis, since 2021. It reported revenue of $65.01B for the period ended December 31, 2025.","title":"Merck & Co.: CEO Rob Davis, revenue $65.01B","key_facts":[{"label":"CEO","value":"Rob Davis","note":"since 2021","claim":"clm_870B389E9A27"},{"label":"Headquarters","value":"Rahway","claim":"clm_BFFD023A5D40"},{"label":"Revenue","value":"$65.01B","recorded":"65,011,000,000 United States dollar","note":"to 2025-12-31","claim":"clm_E778C75FD821"},{"label":"Ticker","value":"MRK · NYSE","claim":"clm_37834FC2D131"}],"faq":[{"question":"Who is the CEO of Merck & Co.?","answer":"Rob Davis, since 2021, as the AsOf record states with its sources."},{"question":"Where is Merck & Co. headquartered?","answer":"Rahway."},{"question":"What is Merck & Co.'s revenue?","answer":"$65.01B for the period ended December 31, 2025."}],"as_of":"2026-11-08","known_by":null,"since":null,"fact_pages":[{"predicate":"ceo","page":"https://asof.is/record/merck/ceo","md":"https://asof.is/record/merck/ceo.md","json":"https://asof.is/v1/entities/merck/ceo"},{"predicate":"headquarters","page":"https://asof.is/record/merck/headquarters","md":"https://asof.is/record/merck/headquarters.md","json":"https://asof.is/v1/entities/merck/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/merck/revenue","md":"https://asof.is/record/merck/revenue.md","json":"https://asof.is/v1/entities/merck/revenue"},{"predicate":"net_income","page":"https://asof.is/record/merck/net_income","md":"https://asof.is/record/merck/net_income.md","json":"https://asof.is/v1/entities/merck/net_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/merck/quarterly_revenue","md":"https://asof.is/record/merck/quarterly_revenue.md","json":"https://asof.is/v1/entities/merck/quarterly_revenue"}],"products":[],"coverage":{"entity":"merck","name":"Merck & Co.","kind":"organization","sources":[{"source":"wikidata","item":"Q247489","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":310158,"ticker":"MRK","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":503,"open":20,"retracted":0,"first":"1891-01-01","predicates":{"quarterly_research_and_development":{"claims":56,"open":1,"kind":"fact"},"shares_outstanding":{"claims":70,"open":1,"kind":"fact"},"total_assets":{"claims":71,"open":1,"kind":"fact"},"net_income":{"claims":19,"open":1,"kind":"fact"},"quarterly_revenue":{"claims":38,"open":1,"kind":"fact"},"quarterly_net_income":{"claims":56,"open":1,"kind":"fact"},"research_and_development":{"claims":19,"open":1,"kind":"fact"},"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"revenue":{"claims":14,"open":1,"kind":"fact"},"total_equity":{"claims":73,"open":1,"kind":"fact"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"x_username":{"claims":1,"open":1,"kind":"identifier"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"cik":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":501,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":2,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_5760FE8DF5CC","predicate":"cash_and_equivalents","value":"9,550,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,550,000,000 United States dollar\", as of 2026-09-30. Claim clm_5760FE8DF5CC, https://asof.is/claim/clm_5760FE8DF5CC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_5760FE8DF5CC","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_870B389E9A27","predicate":"ceo","value":"Rob Davis","valid_from":"2021-07-01","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. ceo: Rob Davis\", as of 2021-07-01. Claim clm_870B389E9A27, https://asof.is/claim/clm_870B389E9A27, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312521106317/d50486ddef14a.htm.","url":"https://asof.is/claim/clm_870B389E9A27","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/310158/000119312521106317/d50486ddef14a.htm","tier":"primary","publisher":null,"published_at":null}],"evidence":{"by":"page-read","on":"2026-11-08","quote":"The Board has unanimously elected Rob Davis as the next CEO, effective July 1, 2021.","url":"https://www.sec.gov/Archives/edgar/data/310158/000119312521106317/d50486ddef14a.htm"}},{"id":"clm_866F817FFD7C","predicate":"cik","value":"0000310158","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cik: 0000310158\", undated. Claim clm_866F817FFD7C, https://asof.is/claim/clm_866F817FFD7C, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_866F817FFD7C","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_D6EE533D837B","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. fiscal year end: 12-31\", undated. Claim clm_D6EE533D837B, https://asof.is/claim/clm_D6EE533D837B, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_D6EE533D837B","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_BFFD023A5D40","predicate":"headquarters","value":"Rahway","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. headquarters: Rahway\", undated. Claim clm_BFFD023A5D40, https://asof.is/claim/clm_BFFD023A5D40, accessed 2026-11-09. Source: https://www.merck.com/contact-us/.","url":"https://asof.is/claim/clm_BFFD023A5D40","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.merck.com/contact-us/","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_88B4EFBC615C","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. listed on: NYSE\", undated. Claim clm_88B4EFBC615C, https://asof.is/claim/clm_88B4EFBC615C, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_88B4EFBC615C","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_23107EF0C145","predicate":"net_income","value":"18,254,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 18,254,000,000 United States dollar\", as of 2025-12-31. Claim clm_23107EF0C145, https://asof.is/claim/clm_23107EF0C145, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_23107EF0C145","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_BE2114005849","predicate":"quarterly_net_income","value":"5,065,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,065,000,000 United States dollar\", as of 2026-09-30. Claim clm_BE2114005849, https://asof.is/claim/clm_BE2114005849, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_BE2114005849","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_8D15B1B2A78D","predicate":"quarterly_research_and_development","value":"4,537,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,537,000,000 United States dollar\", as of 2026-09-30. Claim clm_8D15B1B2A78D, https://asof.is/claim/clm_8D15B1B2A78D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_8D15B1B2A78D","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_D93F566AE261","predicate":"quarterly_revenue","value":"18,085,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 18,085,000,000 United States dollar\", as of 2026-09-30. Claim clm_D93F566AE261, https://asof.is/claim/clm_D93F566AE261, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_D93F566AE261","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_57A2834F3A81","predicate":"registrant_name","value":"Merck & Co., Inc.","valid_from":"2009-11-04","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. registrant name: Merck & Co., Inc.\", as of 2009-11-04. Claim clm_57A2834F3A81, https://asof.is/claim/clm_57A2834F3A81, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_57A2834F3A81","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_062934F11209","predicate":"research_and_development","value":"15,789,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 15,789,000,000 United States dollar\", as of 2025-12-31. Claim clm_062934F11209, https://asof.is/claim/clm_062934F11209, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_062934F11209","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_E778C75FD821","predicate":"revenue","value":"65,011,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 65,011,000,000 United States dollar\", as of 2025-12-31. Claim clm_E778C75FD821, https://asof.is/claim/clm_E778C75FD821, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_E778C75FD821","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-24"}},{"id":"clm_B0FE93A73A8D","predicate":"shares_outstanding","value":"2,465,245,688 shares","valid_from":"2026-10-31","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,465,245,688 shares\", as of 2026-10-31. Claim clm_B0FE93A73A8D, https://asof.is/claim/clm_B0FE93A73A8D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_B0FE93A73A8D","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_7424130E993D","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_7424130E993D, https://asof.is/claim/clm_7424130E993D, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_7424130E993D","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_611073235D86","predicate":"state_of_incorporation","value":"NJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. state of incorporation: NJ\", undated. Claim clm_611073235D86, https://asof.is/claim/clm_611073235D86, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_611073235D86","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_37834FC2D131","predicate":"ticker","value":"MRK","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. ticker: MRK\", undated. Claim clm_37834FC2D131, https://asof.is/claim/clm_37834FC2D131, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158.","url":"https://asof.is/claim/clm_37834FC2D131","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310158","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_700C48638C17","predicate":"total_assets","value":"132,773,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 132,773,000,000 United States dollar\", as of 2026-09-30. Claim clm_700C48638C17, https://asof.is/claim/clm_700C48638C17, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_700C48638C17","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_23DBC8C334E1","predicate":"total_equity","value":"44,893,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,893,000,000 United States dollar\", as of 2026-09-30. Claim clm_23DBC8C334E1, https://asof.is/claim/clm_23DBC8C334E1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_23DBC8C334E1","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-11-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}},{"id":"clm_500A250794EC","predicate":"website","value":"https://www.merck.com","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. website: https://www.merck.com\", undated. Claim clm_500A250794EC, https://asof.is/claim/clm_500A250794EC, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q247489.","url":"https://asof.is/claim/clm_500A250794EC","accessed":"2026-11-09"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Merck | Home.","url":"https://www.merck.com"}},{"id":"clm_6BB2CF8F4BA7","predicate":"x_username","value":"merck","valid_from":"2009-04-27","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. x username: merck\", as of 2009-04-27. Claim clm_6BB2CF8F4BA7, https://asof.is/claim/clm_6BB2CF8F4BA7, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q247489.","url":"https://asof.is/claim/clm_6BB2CF8F4BA7","accessed":"2026-11-09"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q247489","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/Merck","url":"https://www.merck.com"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}